REVIEW
Published on 06 Nov 2012
Genomic and epigenomic alterations in prostate cancer
doi 10.3389/fendo.2012.00128
- 4,260 views
- 13 citations
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Prostate cancer: androgen and estrogen receptors, genomic and epigenomic alterations, metabolic dysregulations and metabolic imaging, molecular diagnostics, preclinical models and novel therapeutic agents
Prostate cancer: androgen and estrogen receptors, genomic and epigenomic alterations, metabolic dysregulations and metabolic imaging, molecular diagnostics, preclinical models and novel therapeutic agents
11k
Total downloads
49k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 18 Jul 2012
A Changing Landscape in Castration-Resistant Prostate Cancer Treatment
doi 10.3389/fendo.2012.00085
- 5,360 views
- 14 citations
REVIEW
Published on 31 May 2012
Emerging Targeted Therapies for Castration-Resistant Prostate Cancer
doi 10.3389/fendo.2012.00073
- 7,674 views
- 22 citations
PERSPECTIVE
Published on 29 May 2012
Prostate cancer – a biomarker perspective
doi 10.3389/fendo.2012.00072
- 7,779 views
- 25 citations
MINI REVIEW
Published on 18 May 2012
FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
doi 10.3389/fendo.2012.00068
- 12,533 views
- 76 citations
MINI REVIEW
Published on 16 May 2012
The genomic landscape of prostate cancer
doi 10.3389/fendo.2012.00069
- 7,312 views
- 43 citations
OPINION
Published on 12 Apr 2012
Is the Bench Getting Closer to the Bedside in the War on Cancer? A Quick Look at Prostate Cancer
doi 10.3389/fendo.2012.00053
- 3,212 views
- 5 citations
Published in
Frontiers in Endocrinology
- Cancer Endocrinology
Impact
- 49kTopic views
- 35kArticle views
- 11kArticle downloads